These 2 value and growth stocks are trading at deep discounts

If you’re looking for value, these two stocks have all the right qualities.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Trying to find attractive value stocks in today’s market is difficult. Most companies are overvalued and those that are not too expensive tend to be nothing but junk. However, I believe I have found two stocks that are both of a high quality and still appear to be cheap. 

Deep discount to book value

Livermore Investment Group (LSE: LIV) is my first pick. It flies under the radar of most investors, even though its market capitalisation is £95m. The company may appear difficult to understand because it is an investment business that invests in property, debt, and equity. Therefore traditional valuation analysis is not appropriate. Instead, the best way of valuing Livermore is to consider the company’s growth net asset value, as well as cash returns to investors. 

At the end of 2016, it reported a net asset value of $0.9 per share, around 71p at current exchange rates. Year-on-year net asset value grew by 16.8%, and the figure above excludes a $15m dividend to investors as well as an $8m share buyback. Including these two cash distributions, adjusted shareholder funds at the end of 2016 would be $180m, up 21% year-on-year. 

Two things stand out about the above numbers. First off, shares in Livermore are currently trading at a 27% discount to book value, which is a highly attractive margin of safety. Secondly, management is returning a healthy amount of cash to investors and buying back stock at a discount to net asset value, which is extremely impressive as such a strategy creates an enormous amount of value for investors. By purchasing shares at a 27% discount to book, management is spending 73p to buy £1. Who would pass up such an attractive offer? 

The one downside to Livermore is that, as an investment company, the firm’s returns are lumpy and not guaranteed. Still, with management set on creating value, investors can take comfort in the fact that over the long term, it will produce positive returns. Over the past year, shares in the company have returned 108%.

Growth and value

Just Group (LSE: JUST), formerly JRP Group looks to be another unloved value play. It is a financial services business, offering products for the retirement market. Thanks to the shakeup of the UK retirement market in recent years, the company has fallen out of favour with the City and investors, but management has managed to stabilise the business, and now earnings per share of 13.4p are pencilled-in for 2017. Earnings growth of 20% is expected for 2018, taking earnings per share to 16.1p and putting the company on a forward P/E of 7.3. 

Even though concerns remain about the viability of the company’s business model in the rapidly changing retirement product market, Just’s low valuation coupled with expected growth in the years ahead, lead me to conclude that the firm is not on the rocks just yet. The low valuation more than makes up for any troubles that might be ahead. Shares in the company currently support a dividend yield of 2.9%. 

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Rupert Hargreaves has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young Caucasian man making doubtful face at camera
Investing Articles

Surprise! This monopoly stock has taken over my Stocks and Shares ISA (again)

Our writer has a (nice) dilemma in his Stocks and Shares ISA portfolio after one incredible growth stock rocketed higher…

Read more »

Investing Articles

10.5% yield – but could the abrdn share price get even cheaper?

Christopher Ruane sees some things to like about the current abrdn share price. But will that be enough to overcome…

Read more »

Investing Articles

£9,000 to invest? These 3 high-yield shares could deliver a £657 annual passive income

The high yields on these dividend shares sail sit well above the FTSE 100 average of 3.6%. Here's why I…

Read more »

Surprised Black girl holding teddy bear toy on Christmas
Investing Articles

I’ve got £2k and I’m on the hunt for cheap shares to buy in December

Harvey Jones finally has some cash in his trading account and is hunting for cheap shares to buy next month.…

Read more »

Investing Articles

Down 25% with a 4.32% yield and P/E of 8.6! Is this my best second income stock or worst?

Harvey Jones bought GSK shares hoping to bag a solid second income stream while nailing down steady share price growth…

Read more »

Investing Articles

Here’s how the Legal & General dividend yield could ultimately hit 15%!

The Legal & General dividend yield is already among the best of any FTSE 100 share. Christopher Ruane explores some…

Read more »

Investing Articles

Is December a good time for me to buy UK shares?

This writer is weighing up which shares to buy for his portfolio next month, and one household name from the…

Read more »

Investing Articles

Is it time to dump my Lloyds shares and never look back?

Harvey Jones was chuffed with his Lloyds shares but recent events have made him rethink his entire decision to go…

Read more »